Spots Global Cancer Trial Database for The AIM Study: Assessing the Impact of Margin Reduction
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: The AIM Study: Assessing the Impact of Margin Reduction
Official Title: The AIM Study: Assessing the Impact of Margin Reduction
Study ID: NCT00754000
Conditions
Interventions
Study Description
Brief Summary: This study will observe patients who receive external beam radiation for prostate cancer. These patients will be localized and tracked (targeted) with the Calypso 4D Localization System. These patients will have a uniform treatment plan with reduced PTVs (prostate treatment volume) and will be assessed at multiple time points for quality of life and side effects related to radiation therapy.
Detailed Description: EPIC surveys and adverse events recorded and categorized using the CTCAE v3.0 will be collected and summary statistics performed. The patient's individual tracking graphs will be evaluated for motion type and frequency.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
21st Century Oncology - Scottsdale, Scottsdale, Arizona, United States
21st Century Oncology - Santa Monica, Santa Monica, California, United States
21st Century Oncology, Cape Coral, Florida, United States
21st Century Oncology - Plantation, Plantation, Florida, United States
Contact Details
Name: Constantine Mantz, MD
Affiliation: GenesisCare USA
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
